학술논문
Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry
Document Type
Abstract
Author
Landsburg, Daniel J.; Frigault, Matthew; Heim, Michael ; Foley, Stephen Ronan; Hill, Brian T.; Ho, Christine M.; Jacobson, Caron A.; Jaglowski, Samantha; Locke, Frederick L.; Ram, Ron ; Riedell, Peter A. ; Shah, Gunjan L. ; Popplewell, Leslie L.; Tiwari, Ranjan ; Lim, Stephen ; Majdan, Marta ; Masood, Aisha; Pasquini, Marcelo C; Turtle, Cameron J.
Source
In Blood 15 November 2022 140 Supplement 1:1584-1587
Subject
Language
ISSN
0006-4971